- 拡大
- Hirokazu Ogino,
Representative Director,
President and Chief Executive Officer
Since 1951, Nihon Kohden has strived to contribute to the world by fighting disease and improving health with advanced technology, as well as create a fulfilling life for employees. This has led to revolutionary technologies and high quality medical devices. Nihon Kohden was founded with just twelve members, but today employs over 6,100 staff as it continues to tackle healthcare challenges around the world.The products developed by Nihon Kohden have been exported to more than 120 countries around the world, where they have been used in various healthcare settings to save the lives of countless patients.
To save the lives of as many patients as possible, Nihon Kohden has continually pursued technological innovation and strived to create higher quality products. The Company’s mission as a medical equipment manufacturer is to provide clinical value as well as value to patients. Nihon Kohden’s strengths lie in its ability to create value for society, primarily through 1) the capacity to develop technologies rooted in medical practice; 2) a broad client base inside and outside Japan; 3) high-quality products and services supported by integrated development, production, sales, and service; and 4) a powerful brand cultivated over many years.
In the Three-year Business Plan, BEACON 2030 Phase II, the phase of the practice of sustainability management, we are embracing sustainability as the essence of our business activities and are working on solving medical, environmental, and social issues.
To contribute to solving medical issues, we have cooperated with related organizations by inviting local doctors to training sessions in Japan to reduce the neonatal mortality rate and serious complications in Indonesia. Through the widespread use of the neonatal resuscitation monitor developed by Nihon Kohden, we support appropriate neonatal resuscitation practices.
To contribute to solving environmental issues, we started certifying our products and services with the Green Product Labels in March 2024. Our products and services are certified based on four evaluation ranks according to their level of contribution to reducing environmental impact. In addition, we also added a business impact assessment to the disclosure based on TCFD*1 recommendations. As a result of these efforts, we received an A- rating for the first time in the area of Water Security from the environmental non-profit organization, CDP. In FY2025, we will advance the collection of Scope 3 data from Japan and overseas to obtain SBT*2 certification.
To contribute to solving social issues, we are further strengthening group governance by ensuring the diversity and internationality of the Board of Directors and further enhancing its supervisory functions. We introduced a CxO framework in April 2024 and appointed two female directors and one foreign director in June 2024, bringing the ratio of independent outside directors to 50%. We have also reviewed the remuneration for executives and introduced a performance-linked stock remuneration plan. The evaluation items include consolidated operating income margin, consolidated ROE, and relative TSR*3.
To achieve the Three-year Business Plan and address key management issues through cross-functional organization, we have appointed COO, CSO, and CAO to assist CEO*4 in April 2025. They are responsible for driving operational excellence, promoting global business strategies, and building a robust administration infrastructure. The Company has also newly established the Neurology Business Division to create synergies with Ad-Tech. In addition, to enhance employees’ motivation and morale toward contributing to medium- to long-term business performance and corporate value of Nihon Kohden, the Company has also introduced an Employee Stock Ownership Plan. FY2025 is a pivotal year for achieving the Three-year Business Plan. We are committed to aligning closely with our shareholders as we work toward realizing a sustainable society and enhancing long-term corporate value.
*1 TCFD: Task Force on Climate-related Financial Disclosures.
*2 SBT: Science Based Targets are greenhouse gas emissions reduction targets set by each company for 5 to 10 years in the future in line with the levels sought under the Paris Agreement.
*3 Relative TSR: (Total shareholder return of the Company at the end of the relevant fiscal year) ÷ (Average of total shareholder return of other companies in the same industry for the period corresponding to the calculation period of total shareholder return of the Company)
*4 CEO: Chief Executive Officer, COO: Chief Operating Officer, CSO: Chief Strategy Officer, CAO: Chief Administrative Officer.
